]>
IRCT20200111046086N1 IRCT 2020-03-31 Tabriz University of Medical Sciences Tamsulosin for treatment of urinary tract disorder in women A comparison of the effect of Tamsulosin and placebo in the treatment of urinary tract disorder in women 2019-08-23 anticipated 252 Complete https://irct.ir/trial/46381 interventional Randomization: Not randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Blinding description: This is a double-blinded study and researcher and patients are kept unaware of intervention in each group and In order to allocation concealment, the type of intervention will be written on paper and placed in numbered, matte and packed envelopes.The envelopes will be opened in the order of participation of the participants and the type of group will be determined. 2-3 Retention of urine. Intervention 1: Intervention group: Tamsulosin capsule with a dose of 0.4 mg made in Iran, one daily for a maximum of 4 weeks. Intervention 2: Control group: placebo capsule made in Iran, one daily for a maximum of 4 weeks. Yes - There is a plan to make this available What will be shared: A portion of the data that represents the final outcome When: Access will be 6 months after the results are printed. To whom: All Physicians and residents of the department of Urology Conditions: After obtaining permission from the deputy research of group Where to obtain: Person responsible for scientific accountability of study How to obtain: First approved by the Research Vice-President Comments:
public Sakineh Haj Eebrahimi
Department of Urology, Imam Reza educational and treatment center, Golgasht Street, Tabriz
Tabriz Iran (Islamic Republic of) 5166614766 +98 41 3334 7054 hajebrahimis@gmail.com Tabriz University of Medical Sciences scientific Sakineh Hajebrahimi
Department of Urology, Imam Reza educational and treatment center, Golgasht Street, Tabriz
Tabriz Iran (Islamic Republic of) 5166614766 +98 41 3334 7054 hajebrahimis@gmail.com Tabriz University of Medical Sciences Iran (Islamic Republic of) Women with at least three months of urinary tract disorder Age between 18 to 65 years old Signing informed consent form 18 years 65 years Female Active urinary tract infection History of neurological disorders Pregnant women Retention R33 Treatment - Drugs Placebo Intervention group: Tamsulosin capsule with a dose of 0.4 mg made in Iran, one daily for a maximum of 4 weeks Control group: placebo capsule made in Iran, one daily for a maximum of 4 weeks Urinary symptoms (urgency; frequency; nocturia; dysuria; incomplete emptying). Timepoint: 1 Weeks after intervention. Method of measurement: Standard questionnaire (USSQ). Tabriz University of Medical Sciences Approved 2020-01-06 Ethics Committee Of Tabriz University Of Medical Sciences. Third Floor, Central Building of Number2, Golgasht Street Tabriz East Azarbaijan Iran (Islamic Republic of)